Ikarian Capital, LLC Biotechnology

Ikarian Capital, LLC

  • $714 Million
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
CORT
Corcept Therapeutics Inc
PUT
$32.9 Million
288K N/A
BBIO
Bridge Bio Pharma, Inc.
CALL
$22.7 Million
655K
Q1 2025
Reduced 57.89%
CORT
Corcept Therapeutics Inc
CALL
$11.4 Million
100K N/A
IMVT
Immunovant, Inc.
PUT
$11 Million
400K
Q4 2024
New holding
RNA
Avidity Biosciences, Inc.
PUT
$8.86 Million
300K N/A
ACLX
Arcellx, Inc.
PUT
$7.32 Million
112K N/A
KYMR
Kymera Therapeutics, Inc.
PUT
$4.84 Million
177K
Q2 2022
Closed
PTGX
Protagonist Therapeutics, Inc
CALL
$4.84 Million
100K
Q4 2024
New holding
PTGX
Protagonist Therapeutics, Inc
PUT
$4.84 Million
100K
Q4 2024
New holding
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$4.1 Million
113K
Q1 2025
Added 21.23%
MLTX
Moon Lake Immunotherapeutics
PUT
$3.69 Million
94.5K N/A
MLTX
Moon Lake Immunotherapeutics
CALL
$3.69 Million
94.5K N/A
INCY
Incyte Corp
CALL
$3.66 Million
60.4K
Q4 2021
Closed
VKTX
Viking Therapeutics, Inc.
CALL
$3.62 Million
150K
Q1 2025
New holding
RARE
Ultragenyx Pharmaceutical Inc.
PUT
$3.62 Million
100K
Q1 2025
Added 21.23%
SRRK
Scholar Rock Holding Corp
CALL
$3.22 Million
100K
Q1 2025
Reduced 31.64%
QURE
Uni Qure N.V.
CALL
$3.18 Million
300K
Q1 2024
Added 198.12%
KYMR
Kymera Therapeutics, Inc.
CALL
$2.74 Million
100K
Q2 2022
Closed
DYN
Dyne Therapeutics, Inc.
CALL
$1.96 Million
187K
Q1 2025
New holding
ARCT
Arcturus Therapeutics Holdings Inc.
CALL
$1.59 Million
150K
Q1 2025
Reduced 12.5%
CMPX
Compass Therapeutics, Inc.
CALL
$1.26 Million
662K
Q2 2022
Closed
CMPX
Compass Therapeutics, Inc.
PUT
$1.26 Million
662K
Q2 2022
Closed
PRTA
Prothena Corp Public LTD CO
CALL
$1.24 Million
100K
Q2 2021
Closed
ALT
Altimmune, Inc.
PUT
$1.2 Million
240K
Q1 2023
Added 147.7%
CRVS
Corvus Pharmaceuticals, Inc.
CALL
$1.08 Million
338K
Q2 2022
Closed
IMUX
Immunic, Inc.
CALL
$693,000
636K
Q1 2025
Reduced 43.37%
CELC
Celcuity Inc.
PUT
$403,000
39.9K N/A
CLDX
Celldex Therapeutics, Inc.
PUT
$323,000
17.8K
Q1 2023
Reduced 60.35%
CLDX
Celldex Therapeutics, Inc.
CALL
$323,000
17.8K
Q1 2023
Reduced 60.35%
CRVS
Corvus Pharmaceuticals, Inc.
PUT
$159,000
50K
Q2 2022
Closed
CELC
Celcuity Inc.
CALL
$150,000
14.9K N/A
Filter Shares Options
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email